EBRCZ · XBRL financial data

EBR Systems financial statements, every quarter

The same tables from 8 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (EBRCZ's year ends in late December)

In thousands of dollars	Q3 FY24Oct 16, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26†Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	—	—	—	170	512	935*	2,362	2,637
Cost of revenue	—	—	—	85	288	year only	2,178	2,294
Gross profit	—	—	—	84	224	—	184	343
Research and development	—	6,894*	5,419	5,952	6,244	6,326*	6,417	6,620
General and administrative	—	2,932*	4,363	5,265	5,861	7,149*	9,939	10,120
Total operating expenses	—	9,826*	9,782	11,216	12,105	13,474*	16,356	16,740
Operating income (loss)	—	(9,826)*	(9,782)	(11,132)	(11,881)	(13,293)*	(16,172)	(16,397)
Interest income	—	831*	633	614	818	642*	414	282
Interest expense	—	1,470*	1,397	1,431	1,425	1,391*	1,316	1,335
Other income (expense)	—	351*	—	19	304	0*	—	—
Income tax expense (benefit)	—	2*	0	0	0	2*	—	—
Net income (loss)	—	(10,098)*	(10,554)	(11,967)	(12,189)	(14,047)*	(17,074)	(17,453)
Earnings per share, basic USD per share	—	(0.03)*	(0.03)	(0.03)	(0.03)	(0.03)*	(0.38)	(0.35)
Earnings per share, diluted USD per share	—	(0.03)*	(0.03)	(0.03)	(0.03)	(0.03)*	(0.38)	(0.35)
Weighted average shares, basic thousands of shares	—	372,889*	372,541	395,862	449,681	450,018*	45,038	49,236
Weighted average shares, diluted thousands of shares	—	372,889*	372,541	395,862	449,681	450,018*	45,038	49,236

† Share count changed about 1/10 in the period ending 2026-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal quarters (EBRCZ's year ends in late December)

In thousands of dollars	Q3 FY24Oct 16, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26†Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	—	6,918	8,899	44,993	12,642	5,794	6,558	59,350
Marketable securities	—	53,746	38,968	36,705	55,722	47,395	23,315	26,590
Marketable securities, non-current	—	5,304	2,319	2,900	2,032	1,011	1,006	1,003
Inventory	—	2,843	4,718	5,134	9,689	13,789	15,492	17,585
Total current assets	—	64,466	53,478	90,345	82,231	73,111	54,044	110,150
Property and equipment, net	—	795	1,244	3,009	3,186	5,477	8,770	9,195
Right-of-use asset	—	929	13,470	13,184	12,898	12,613	12,263	12,042
Total assets	—	73,559	75,501	114,930	104,992	97,226	80,286	138,675
Accounts payable	—	3,247	2,749	4,767	4,590	7,049	5,765	4,097
Total current liabilities	—	8,328	6,727	9,688	10,351	14,048	12,071	52,023
Lease liability, non-current	—	575	13,563	14,767	15,057	16,520	17,397	17,436
Total liabilities	—	49,204	60,942	65,234	66,341	71,638	70,748	69,818
Accumulated deficit	—	(353,458)	(364,012)	(375,979)	(388,168)	(402,216)	(419,290)	(436,743)
Total stockholders' equity	—	24,356	14,559	49,696	38,651	25,588	9,538	68,857
Total liabilities and equity	—	73,559	75,501	114,930	104,992	97,226	80,286	138,675
Common shares outstanding (cover page) thousands of shares	370,776	372,851	373,077	449,552	449,995	450,436	45,056	75,336

† Share count changed about 1/10 in the period ending 2026-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal quarters (EBRCZ's year ends in late December)

In thousands of dollars	Q3 FY24Oct 16, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26†Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	—	(10,098)*	(10,554)	(11,967)	(12,189)	(14,047)*	(17,074)	(17,453)
Stock-based compensation	—	486*	505	704	929	913*	907	936
Depreciation and amortization	—	91*	79	118*	90*	115*	125	284*
Net cash from operating activities	—	(10,987)*	(13,564)	(11,477)*	(13,141)*	(15,011)*	(20,251)	(17,194)*
Purchases of property and equipment	—	66*	60	888*	1,278*	1,457*	3,290	2,851*
Net cash from investing activities	—	(21,171)*	17,906	896*	(19,084)*	8,117*	20,882	(6,183)*
Proceeds from issuing common stock	—	2,762*	—	—	0*	(0)*	—	—
Net cash from financing activities	—	2,682*	242	46,668*	(138)*	57*	132	76,192*
Net change in cash	—	(29,494)*	4,585	36,094*	(32,352)*	(6,848)*	764	52,792*

† Share count changed about 1/10 in the period ending 2026-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
EBR Systems	59,350	2,637	(17,194)*	75.3M	5.0 quarters	Q2 FY26 10-QJun 30, 2026
Orthopediatrics	17,141	72,661	4,506*	26.1M	—	Q3 FY26 10-QSep 30, 2026
Outset Medical	35,005	31,635	(9,635)*	18.8M	15.3 quarters	Q2 FY26 10-QJun 30, 2026
ClearPoint Neuro	46,184	12,075	(20,100)	32.1M	6.6 quarters	Q3 FY26 10-QSep 30, 2026
Butterfly Network	122,301	32,598	(2,266)*	not reported	10.3 quarters	Q3 FY26 10-QSep 30, 2026
Pulse Biosciences	101,620	434	(18,709)*	71.3M	5.4 quarters	Q2 FY26 10-QJun 30, 2026
NeuroPace	12,538	22,826	(3,903)*	34.3M	13.2 quarters	Q2 FY26 10-QJun 30, 2026
Ceribell	41,989	29,341	(13,078)*	38.8M	7.8 quarters	Q3 FY26 10-QSep 30, 2026
Delcath Systems	47,521	29,133	5,712*	34.7M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.